Owner Novartis AG IRM, LLC

Inventors Ding, Qiang; Zhang, Guobao; Pissot Soldermann, Carole; Spanka, Carsten; Furet, Pascal; Bold, Guido; Uno, Tetsuo; Manley, Paul W.; Lang, Marc; Sim, Taebo; Gray, Nathanael Schiander; Li, Bing; Liu, Yi; Caravatti, Giorgio; Breitenstein, Werner; Guagnano, Vito; Schoepfer, Joseph

Agent Davies Collison Cave

Pub. Number AU-B-2009213036

Parent 2005256491

Filing date 10 September 2009

Wipo publication date 8 October 2009

Acceptance publication date 19 May 2011

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 251/48 (2006.01) Heterocyclic compounds containing 1,3,5-triazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms